Amorphous object of cinnamide compound

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/06 (2006.01) A61K 31/454 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2580119

An amorphous object of (3E)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4- (4~methyl-1H-imidazol-1-yl)benzylidene]piperidine-2-one, which is represented by the formula (1) and has A.beta.-production inhibitory activity. The amorphous object has such satisfactory properties that it has excellent solubility, is stable, does not readily become a crystalline form, and has low hygroscopicity. It is hence suitable for use in pharmaceutical preparations.

La présente invention a pour objet une forme amorphe de la (3E)-1-[(1S)-1-(4-fluorophényl)éthyl]-3-[3-méthoxy-4-(4-­méthyl-1H-imidazol-1-yl)benzylidène]pipéridine-2-one, de formule (1) qui présente un effet inhibiteur de la production de A.beta.. Ladite forme amorphe présente une excellente solubilité, est stable, ne se transforme pas spontanément en une forme cristalline, et se révèle faiblement hygroscopique. Elle est donc adaptée à une utilisation dans des préparations pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Amorphous object of cinnamide compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amorphous object of cinnamide compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amorphous object of cinnamide compound will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1393999

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.